GLP-1s

Numerous resources and strategies exist for physicians seeking to help patients with opioid use disorder access specialized care, according to AMA Wire.

Evanston, Ill.-based Northshore University HealthSystem's center for personalized medicine rolled out a new test to assess patients' risk of developing prostate cancer.

The National Institutes of Health awarded seven institutions $28.6 million to establish three genome centers as part of the All of Us Research Program.

Richard Sackler, MD, whose family owns Purdue Pharma, earned a patent for a new formulation of buprenorphine, according to STAT.

Purdue Pharma will donate $3.4 million to the nonprofit drug company Harm Reduction Therapeutics to develop a cheaper opioid overdose antidote.

Many companies and scientists are stepping up developmental efforts to make less addictive pain medications amid the ongoing opioid epidemic, according to Science.

A study published in JAMA Surgery examined the types of interventions that are effective for improving stewardship in opioid prescribing postsurgery.

Young adults between ages 13 and 30 who fill an opioid prescription before or after having their wisdom teeth are 2.7 times more likely to demonstrate continued opioid use, according to a study published in JAMA.

A study, published in The BMJ, examined trends in the rate and daily dose of opioids used among commercial and Medicare Advantage beneficiaries over a nine-year period.

A quick search for “opioid-use disorder” (OUD) brings up thousands of news articles from all over the country. It’s a high-profile problem—one that almost everyone is aware of, from senior public health officials in the federal government to the layperson…